Compile Data Set for Download or QSAR
Report error Found 75 Enz. Inhib. hit(s) with all data for entry = 13477
TargetDimer of Receptor-type tyrosine-protein kinase FLT3 [D835V](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.0580nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [D835V](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.0620nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796570BDBM796570((17E)-8,12,14,16-tetramethyl- 2,11,12,14-tetrahydr...)
Affinity DataIC50: 0.0730nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796572BDBM796572((17E)-14-ethyl-8,12,16-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.0840nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.0880nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796575BDBM796575((17E)-16-ethoxy-8,12,14-trimethyl- 2,11,12,14-tetr...)
Affinity DataIC50: 0.0930nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.115nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.134nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796578BDBM796578((18E)-8,10,13,15,17-pentamethyl- 2,8,9,10,11,12,13...)
Affinity DataIC50: 0.157nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796579BDBM796579((17E)-14-(2-hydroxyethyl)-8,12,16- trimethyl-2,11,...)
Affinity DataIC50: 0.160nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796578BDBM796578((18E)-8,10,13,15,17-pentamethyl- 2,8,9,10,11,12,13...)
Affinity DataIC50: 0.161nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.165nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.180nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796574BDBM796574((17E)-8,12,16-trimethyl-14-(propan-2- yl)-2,11,12,...)
Affinity DataIC50: 0.187nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796570BDBM796570((17E)-8,12,14,16-tetramethyl- 2,11,12,14-tetrahydr...)
Affinity DataIC50: 0.217nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796569BDBM796569((17E)-16-ethyl-8,12,15-trimethyl- 2,11,12,15-tetra...)
Affinity DataIC50: 0.221nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796576BDBM796576((10S,17E)-16-ethyl-8,10,12,14- tetramethyl-2,11,12...)
Affinity DataIC50: 0.225nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3 [F691L](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.230nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.230nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796580BDBM796580((18E)-15-(2-hydroxyethyl)-8,10,13,17- tetramethyl-...)
Affinity DataIC50: 0.233nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796569BDBM796569((17E)-16-ethyl-8,12,15-trimethyl- 2,11,12,15-tetra...)
Affinity DataIC50: 0.247nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796575BDBM796575((17E)-16-ethoxy-8,12,14-trimethyl- 2,11,12,14-tetr...)
Affinity DataIC50: 0.253nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796579BDBM796579((17E)-14-(2-hydroxyethyl)-8,12,16- trimethyl-2,11,...)
Affinity DataIC50: 0.299nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796571BDBM796571((17E)-8,12,15,16-tetramethyl- 2,11,12,15-tetrahydr...)
Affinity DataIC50: 0.347nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.348nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796575BDBM796575((17E)-16-ethoxy-8,12,14-trimethyl- 2,11,12,14-tetr...)
Affinity DataIC50: 0.355nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796580BDBM796580((18E)-15-(2-hydroxyethyl)-8,10,13,17- tetramethyl-...)
Affinity DataIC50: 0.386nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.415nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796576BDBM796576((10S,17E)-16-ethyl-8,10,12,14- tetramethyl-2,11,12...)
Affinity DataIC50: 0.416nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.446nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.475nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796570BDBM796570((17E)-8,12,14,16-tetramethyl- 2,11,12,14-tetrahydr...)
Affinity DataIC50: 0.487nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796575BDBM796575((17E)-16-ethoxy-8,12,14-trimethyl- 2,11,12,14-tetr...)
Affinity DataIC50: 0.527nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796578BDBM796578((18E)-8,10,13,15,17-pentamethyl- 2,8,9,10,11,12,13...)
Affinity DataIC50: 0.530nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796569BDBM796569((17E)-16-ethyl-8,12,15-trimethyl- 2,11,12,15-tetra...)
Affinity DataIC50: 0.537nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796573BDBM796573((17E)-8,12,16-trimethyl-15-[2- (pyrrolidin-1-yl)et...)
Affinity DataIC50: 0.564nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796572BDBM796572((17E)-14-ethyl-8,12,16-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.566nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796571BDBM796571((17E)-8,12,15,16-tetramethyl- 2,11,12,15-tetrahydr...)
Affinity DataIC50: 0.592nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.593nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796580BDBM796580((18E)-15-(2-hydroxyethyl)-8,10,13,17- tetramethyl-...)
Affinity DataIC50: 0.605nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796575BDBM796575((17E)-16-ethoxy-8,12,14-trimethyl- 2,11,12,14-tetr...)
Affinity DataIC50: 0.668nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.670nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796579BDBM796579((17E)-14-(2-hydroxyethyl)-8,12,16- trimethyl-2,11,...)
Affinity DataIC50: 0.758nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796574BDBM796574((17E)-8,12,16-trimethyl-14-(propan-2- yl)-2,11,12,...)
Affinity DataIC50: 0.775nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796576BDBM796576((10S,17E)-16-ethyl-8,10,12,14- tetramethyl-2,11,12...)
Affinity DataIC50: 0.843nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [R834Q](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.890nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796576BDBM796576((10S,17E)-16-ethyl-8,10,12,14- tetramethyl-2,11,12...)
Affinity DataIC50: 0.967nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796573BDBM796573((17E)-8,12,16-trimethyl-15-[2- (pyrrolidin-1-yl)et...)
Affinity DataIC50: 1.05nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796581BDBM796581((17E)-16-ethoxy-14-(2-hydroxyethyl)- 8,12-dimethyl...)
Affinity DataIC50: 1.11nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796576BDBM796576((10S,17E)-16-ethyl-8,10,12,14- tetramethyl-2,11,12...)
Affinity DataIC50: 1.39nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details
US Patent

Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: